Compare Stocks: PROF, DRTS, PRCT, and INMD

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRTS Alpha Tau Medical	$11.69 -1.7%	$11.21	$2.87 ▼ $14.11	$1.06B	1.17	596,885 shs	33,234 shs
INMD InMode	$15.04 -0.4%	$14.35	$12.72 ▼ $16.74	$864.21M	1.91	928,362 shs	17,885 shs
PRCT PROCEPT BioRobotics	$18.15 +0.8%	$22.60	$16.67 ▼ $51.38	$1.03B	0.87	1.56 million shs	61,759 shs
PROF Profound Medical	$7.22 -0.5%	$6.86	$3.76 ▼ $8.95	$262.20M	0.73	158,160 shs	781 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRTS Alpha Tau Medical	+6.35%	-10.20%	-5.48%	+42.57%	+310.00%
INMD InMode	-0.33%	+0.07%	+3.28%	+4.35%	+8.63%
PRCT PROCEPT BioRobotics	+0.67%	+2.56%	-20.28%	-25.12%	-64.95%
PROF Profound Medical	+0.14%	+5.84%	+9.02%	+8.21%	+30.63%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DRTS Alpha Tau Medical	$11.69 -1.7%	$11.21	$2.87 ▼ $14.11	$1.06B	1.17	596,885 shs	33,234 shs
INMD InMode	$15.04 -0.4%	$14.35	$12.72 ▼ $16.74	$864.21M	1.91	928,362 shs	17,885 shs
PRCT PROCEPT BioRobotics	$18.15 +0.8%	$22.60	$16.67 ▼ $51.38	$1.03B	0.87	1.56 million shs	61,759 shs
PROF Profound Medical	$7.22 -0.5%	$6.86	$3.76 ▼ $8.95	$262.20M	0.73	158,160 shs	781 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DRTS Alpha Tau Medical	+6.35%	-10.20%	-5.48%	+42.57%	+310.00%
INMD InMode	-0.33%	+0.07%	+3.28%	+4.35%	+8.63%
PRCT PROCEPT BioRobotics	+0.67%	+2.56%	-20.28%	-25.12%	-64.95%
PROF Profound Medical	+0.14%	+5.84%	+9.02%	+8.21%	+30.63%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DRTS Alpha Tau Medical	2.38	Hold	$12.60	5.97% Upside
INMD InMode	2.00	Hold	$16.00	5.96% Upside
PRCT PROCEPT BioRobotics	2.27	Hold	$33.45	85.86% Upside
PROF Profound Medical	2.67	Moderate Buy	$11.50	58.62% Upside

Current Analyst Ratings Breakdown

Latest PROF, DRTS, PRCT, and INMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/29/2026	PROF Profound Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/28/2026	PRCT PROCEPT BioRobotics	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$20.00
7/27/2026	PROF Profound Medical	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Outperform ➝ Strong-Buy	$11.00
7/23/2026	DRTS Alpha Tau Medical	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/22/2026	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$15.00
7/17/2026	DRTS Alpha Tau Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	PRCT PROCEPT BioRobotics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/16/2026	DRTS Alpha Tau Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$15.00
7/14/2026	PROF Profound Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/2/2026	PRCT PROCEPT BioRobotics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$30.00 ➝ $25.00
7/2/2026	PRCT PROCEPT BioRobotics	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold

(Data available from 7/31/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	$0.88 per share	N/A
INMD InMode	$370.49M	2.34	$1.49 per share	10.15	$10.78 per share	1.40
PRCT PROCEPT BioRobotics	$308.05M	3.33	N/A	N/A	$6.55 per share	2.75
PROF Profound Medical	$18.81M	14.00	N/A	N/A	$1.83 per share	3.96

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DRTS Alpha Tau Medical	-$42.63M	-$0.67	N/A	N/A	N/A	N/A	-73.23%	-52.90%	8/10/2026 (Estimated)
INMD InMode	$93.83M	$1.36	11.10	N/A	N/A	23.27%	13.47%	11.95%	N/A
PRCT PROCEPT BioRobotics	-$95.57M	-$1.82	N/A	N/A	N/A	-31.82%	-27.70%	-20.29%	8/4/2026 (Estimated)
PROF Profound Medical	-$42.57M	-$1.24	N/A	N/A	N/A	-206.76%	-78.88%	-64.06%	8/6/2026 (Estimated)

Latest PROF, DRTS, PRCT, and INMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/10/2026	Q2 2026	DRTS Alpha Tau Medical	-$0.14	N/A	N/A	N/A	$0.14 million	N/A
8/6/2026	Q2 2026	PROF Profound Medical	-$0.22	N/A	N/A	N/A	$4.75 million	N/A
8/4/2026	Q2 2026	PRCT PROCEPT BioRobotics	-$0.46	N/A	N/A	N/A	$92.77 million	N/A
5/18/2026	Q1 2026	DRTS Alpha Tau Medical	-$0.13	-$0.26	-$0.13	-$0.26	$0.05 million	N/A
5/7/2026	Q1 2026	PROF Profound Medical	-$0.24	-$0.19	+$0.05	$0.19	$4.85 million	$5.34 million
5/6/2026	Q1 2026	INMD InMode	$0.2978	$0.25	-$0.0478	$0.18	$79.84 million	$82.02 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DRTS Alpha Tau Medical	N/A	N/A	N/A	N/A	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DRTS Alpha Tau Medical	0.09	7.79	7.79
INMD InMode	N/A	8.80	7.88
PRCT PROCEPT BioRobotics	0.15	6.73	5.51
PROF Profound Medical	N/A	6.56	5.71

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DRTS Alpha Tau Medical	2.65%
INMD InMode	68.04%
PRCT PROCEPT BioRobotics	89.46%
PROF Profound Medical	47.86%

Insider Ownership

Company	Insider Ownership
DRTS Alpha Tau Medical	39.50%
INMD InMode	6.92%
PRCT PROCEPT BioRobotics	4.00%
PROF Profound Medical	1.52%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DRTS Alpha Tau Medical	80	90.33 million	54.65 million	No Data
INMD InMode	480	57.48 million	53.50 million	Optionable
PRCT PROCEPT BioRobotics	430	56.92 million	54.64 million	Optionable
PROF Profound Medical	150	36.34 million	35.79 million	Optionable

PROF, DRTS, PRCT, and INMD Headlines

Recent News About These Companies

Profound Medical (PROF) Projected to Release Earnings on Thursday

July 30 at 8:10 AM | marketbeat.com

Profound Medical (NASDAQ:PROF) Raised to Strong-Buy at Raymond James Financial

July 29 at 1:24 AM | americanbankingnews.com

Profound Medical (NASDAQ:PROF) Stock Rating Upgraded by Raymond James Financial

July 27, 2026 | marketbeat.com

Profound Medical Corp. (PRN.TO) Stock: Advances as Study Shows TULSA Outperforms Robotic Surgery on Key Quality-of-Life Measures

July 24, 2026 | blockonomi.com

Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial

July 24, 2026 | financialpost.comF

Robotic Radical Prostatectomy Comes Up ‘Short' in CAPTAIN Trial

July 24, 2026 | globenewswire.com

Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow

July 16, 2026 | financialpost.comF

Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow

July 16, 2026 | globenewswire.com

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

July 15, 2026 | financialpost.comF

Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026

July 15, 2026 | globenewswire.com

Profound Medical (NASDAQ:PROF) Shares Up 1.6% - What's Next?

July 14, 2026 | marketbeat.com

Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?

July 7, 2026 | zacks.com

Profound Medical Corp. (PROF) Dropped Despite High Potential

June 22, 2026 | insidermonkey.com

Profound Medical Corp PROF

May 27, 2026 | morningstar.comM

Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?

May 18, 2026 | zacks.com

Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026

May 14, 2026 | financialpost.comF

Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026

May 14, 2026 | globenewswire.com

Profound Medical Annual General and Special Meeting of Shareholders Voting Results

May 13, 2026 | newsfilecorp.comN

Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates

May 7, 2026 | zacks.com

Profound Medical Reports Strong First Quarter 2026 Financial Results

May 7, 2026 | financialpost.comF

Profound Medical Reports Strong First Quarter 2026 Financial Results

May 7, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PROF, DRTS, PRCT, and INMD Company Descriptions

Alpha Tau Medical NASDAQ:DRTS

$11.69 -0.20 (-1.67%)

As of 10:06 AM Eastern

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

InMode NASDAQ:INMD

$15.04 -0.07 (-0.43%)

As of 10:07 AM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

PROCEPT BioRobotics NASDAQ:PRCT

$18.15 +0.15 (+0.81%)

As of 10:07 AM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Profound Medical NASDAQ:PROF

$7.22 -0.04 (-0.48%)

As of 10:04 AM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PROF, DRTS, PRCT, and INMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PROF, DRTS, PRCT, and INMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PROF, DRTS, PRCT, and INMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PROF, DRTS, PRCT, and INMD Company Descriptions

Alpha Tau Medical NASDAQ:DRTS

InMode NASDAQ:INMD

PROCEPT BioRobotics NASDAQ:PRCT

Profound Medical NASDAQ:PROF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PROF, DRTS, PRCT, and INMD Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PROF, DRTS, PRCT, and INMD Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PROF, DRTS, PRCT, and INMD Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PROF, DRTS, PRCT, and INMD Company Descriptions

Alpha Tau Medical NASDAQ:DRTS

InMode NASDAQ:INMD

PROCEPT BioRobotics NASDAQ:PRCT

Profound Medical NASDAQ:PROF

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools